These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 21256140)

  • 1. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.
    Halberstadt AL; Geyer MA
    Neuropharmacology; 2011 Sep; 61(3):364-81. PubMed ID: 21256140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA; Harvey JA; Aloyo VJ
    Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
    Arvanov VL; Liang X; Russo A; Wang RY
    Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.
    Halberstadt AL
    Behav Brain Res; 2015 Jan; 277():99-120. PubMed ID: 25036425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration.
    Nichols CD; Garcia EE; Sanders-Bush E
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):182-8. PubMed ID: 12654518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and hallucinogens.
    Aghajanian GK; Marek GJ
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):16S-23S. PubMed ID: 10432484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV antiretroviral drug efavirenz has LSD-like properties.
    Gatch MB; Kozlenkov A; Huang RQ; Yang W; Nguyen JD; González-Maeso J; Rice KC; France CP; Dillon GH; Forster MJ; Schetz JA
    Neuropsychopharmacology; 2013 Nov; 38(12):2373-84. PubMed ID: 23702798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
    González-Maeso J; Weisstaub NV; Zhou M; Chan P; Ivic L; Ang R; Lira A; Bradley-Moore M; Ge Y; Zhou Q; Sealfon SC; Gingrich JA
    Neuron; 2007 Feb; 53(3):439-52. PubMed ID: 17270739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5-HT
    Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
    Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological effects of hallucinogens on serotonergic neuronal systems.
    McCall RB
    Neurosci Biobehav Rev; 1982; 6(4):509-14. PubMed ID: 7177511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
    Winter JC
    Psychopharmacology (Berl); 2009 Apr; 203(2):251-63. PubMed ID: 18979087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of serotonin in addiction vulnerability.
    Kirby LG; Zeeb FD; Winstanley CA
    Neuropharmacology; 2011 Sep; 61(3):421-32. PubMed ID: 21466815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.